TerminatedPhase 1NCT00101205

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Studying Angioimmunoblastic T-cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Lisa McGregor
St. Jude Children's Research Hospital
Intervention
oxaliplatin(drug)
Enrollment
40 enrolled
Eligibility
21 years · All sexes
Timeline
2004

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00101205 on ClinicalTrials.gov

Other trials for Angioimmunoblastic T-cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Angioimmunoblastic T-cell lymphoma →

← Back to all trials